EP3893924
Mótefni gegn mennskum magnaþætti C2b og aðferðir til notkunar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.12.2019EP published:
21.8.2024EP application number:
19832737.1
EP translation filed:
21.10.2024Grant published:
15.11.2024EPO information:
European Patent Register
Max expiry date:
12.12.2039Expiry date:
12.12.2026Next due date:
31.12.2026
Title in English:
ANTIBODIES TO HUMAN COMPLEMENT FACTOR C2B AND METHODS OF USELanguage of the patent:
English
Timeline
Today
13.12.2019EP application
21.8.2024EP Publication
21.10.2024Translation submitted
15.11.2024Registration published
12.12.2026Expires
Owner
Name:
argenx BVAddress:
Industriepark 7, 9052 Zwijnaarde, BE
Inventor
Name:
BLANCHETOT, ChristopheAddress:
9070 Destelbergen, BE
Name:
DE HAARD, HansAddress:
NA 4436 Oudelande, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862779102 PDate:
13.12.2018Country:
US
Classification
Categories:
A61K 39/00, A61K 39/395, A61P 35/02, C07K 16/28, C07K 16/30, A61P 37/06, C07K 14/435, C07K 16/18
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 6.12.2024
Expires: 12.12.2025
Payer: CPA Global (Patrafee) AB
Number: 7
Paid: 29.12.2025
Expires: 12.12.2026
Payer: CPA Global (Patrafee) AB